Mutant Phosphatidylinositol 3-kinase CA (PIK3CA) stimulates the AKT pathway and promotes cell growth in several cancers, including ESCC and Non-small cell lung cancer (NSCLC) being associated in these cases with poor prognosis[22]. The gene discussed is PIK3CA; the disease is non-small cell lung carcinoma.